Technical Analysis for ABOS - Acumen Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 2.94 | -1.34% | -0.04 |
ABOS closed down 1.34 percent on Friday, May 31, 2024, on 1.43 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Below Lower BB | Weakness | -1.34% | |
| Down 3 Days in a Row | Weakness | -1.34% | |
| Lower Bollinger Band Touch | Weakness | -1.34% |
| Alert | Time |
|---|---|
| Possible NR7 | 1 day ago |
| Down 2 % | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
| Down 1% | 1 day ago |
| 60 Minute Opening Range Breakdown | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/14/2024
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Immunotherapy Alzheimer's Disease Neurodegenerative Diseases Amyloid Amyloidosis Neurodegeneration Regulus Therapeutics Targeted Immunotherapy Treatment Of Alzheimer's Amyloid Beta
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Immunotherapy Alzheimer's Disease Neurodegenerative Diseases Amyloid Amyloidosis Neurodegeneration Regulus Therapeutics Targeted Immunotherapy Treatment Of Alzheimer's Amyloid Beta
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.3099 |
| 52 Week Low | 1.8101 |
| Average Volume | 258,635 |
| 200-Day Moving Average | 3.75 |
| 50-Day Moving Average | 3.57 |
| 20-Day Moving Average | 3.46 |
| 10-Day Moving Average | 3.39 |
| Average True Range | 0.23 |
| RSI (14) | 33.33 |
| ADX | 20.41 |
| +DI | 14.66 |
| -DI | 28.79 |
| Chandelier Exit (Long, 3 ATRs) | 3.24 |
| Chandelier Exit (Short, 3 ATRs) | 3.58 |
| Upper Bollinger Bands | 3.98 |
| Lower Bollinger Band | 2.94 |
| Percent B (%b) | 0.0 |
| BandWidth | 29.91 |
| MACD Line | -0.11 |
| MACD Signal Line | -0.04 |
| MACD Histogram | -0.0712 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.20 | ||||
| Resistance 3 (R3) | 3.21 | 3.14 | 3.15 | ||
| Resistance 2 (R2) | 3.14 | 3.08 | 3.13 | 3.14 | |
| Resistance 1 (R1) | 3.04 | 3.03 | 3.01 | 3.03 | 3.12 |
| Pivot Point | 2.97 | 2.97 | 2.95 | 2.96 | 2.97 |
| Support 1 (S1) | 2.87 | 2.91 | 2.84 | 2.86 | 2.76 |
| Support 2 (S2) | 2.80 | 2.86 | 2.79 | 2.74 | |
| Support 3 (S3) | 2.70 | 2.80 | 2.73 | ||
| Support 4 (S4) | 2.69 |
